<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 4 Issue 3 </issue_number>
<issue_period>2013 (July - September)</issue_period>
<title>DEVELOPMENT AND VALIDATION OF DERIVATIVE SPECTOSCOPIC METHODFOR SIMULTANEOUS DETERMINATION OF NEBIVOLOL HYDROCHLORIDE AND S-AMLODIPINE BESYLATE IN COMBINED DOSAGE FORM</title>
<abstract>A novel, simple, accurate, sensitive, reproducible, economical spectroscopic method has been developed and validated for the determination of Nebivolol hydrochloride and S-amlodipine besylate in combined dosage form. The method obeys Beer's Law in concentration range of 15-35 µg/ml for Nebivolol and 7.5-17.5 µg/ml for S-amlodipine. The method was validated for linearity, range, accuracy, precision and specificity as per ICH guidelines. Zero crossing point for Nebivolol hydrochloride and S-amlodipine besylate was 243 nm and 291 nm respectively in methanol. The developed method as successfully used for the quantitative analysis of commercially available dosage form (Nebicard SM).</abstract>
<authors>DR. ATUL PATEL</authors>
<keywords>Nebivolol hydrochloride, S-amlodipine besylate, Derivative Spectroscopy, Zero crossing point, combined dosage form. </keywords>
<pages>379-391</pages>
</article>
</Journal>
